Top Markets
#1 Bedrock Bedrock +50.85%
#2 pippin pippin +21.68%
#3 IQ IQ +20.70%
#4 Naoris Protocol Naoris Protocol +17.39%
#5 Irys Irys +16.18%
#6 Magma Finance Magma Finance +15.58%
#7 ETHGas ETHGas +15.36%
#8 Aria.AI Aria.AI +15.19%
#9 パンチ (Punch) パンチ (Punch) +14.59%
#10 Bitway Bitway +12.30%
Coin of the day
Bedrock Bedrock
설정
언어
한국어
통화
USD
테마
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
주식 순위 #20442
Fusion Antibodies plc, a contract research organization, engages in the... Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.
주가
$0.16328419
시가총액
$204.14K
변동 (1일)
4.35%
변동 (1년)
102.45%
국가
GB
거래 Fusion Antibodies plc (FAB)

카테고리

Healthcare
Fusion Antibodies plc (FAB)의 P/S 비율
March 2026 기준 P/S 비율 TTM: 9.79
Fusion Antibodies plc의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 9.79입니다. 2024년 말 기준 P/S 비율은 1.88였습니다.
Fusion Antibodies plc의 P/S 비율 기록 (2013 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
2026 (TTM) 9.79 226.39%
2025 3.00 59.38%
2024 1.88 -45.47%
2023 3.45 6.43%
2022 3.24 -66.20%
2021 9.60 78.11%
2020 5.39 86.72%
2019 2.89 -54.34%
2018 6.32 -55.67%
2017 14.25 -22.61%
2016 18.42 -38.61%
2015 30.00 -20.48%
2014 37.73 -43.99%
2013 67.37 0.00%
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -63.73%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 1.13%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -44.83%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -37.31%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.90 31.71%
NL